TheraPure™ Modifying Enzymes
TheraPure™ Modifying Enzymes
Thermo Scientific™

TheraPure™ Modifying Enzymes

Thermo Scientific TheraPure in vitro transcription (IVT) enzymes are designed for advanced research and early development of mRNA therapeutics and vaccines.
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidadConcentraciónTipo de producto
EN052T15000 U, 100 μL50 U/μlADNasa I, sin ARNasa
EO038T110 000 U, 250 μL40 U/μlInhibidor de la RNasa
EF0221T110 U, 10 μL1 U/μlPirofosfatasa, inorgánica
EF022T110 U, 100 μL0,1 U/μlPirofosfatasa, inorgánica
Número de catálogo EN052T1
Precio (MXN)
-
Cantidad:
5000 U, 100 μL
Concentración:
50 U/μl
Tipo de producto:
ADNasa I, sin ARNasa
Thermo Scientific TheraPure in vitro transcription (IVT) enzymes are designed for advanced research and early development of mRNA therapeutics and vaccines. These products offer full workflow solutions from template preparation to RNA synthesis and are recommended for process research and optimization, proof of concept, and preclinical studies.

The high purity of TheraPure IVT enzymes is ensured by precise quality testing that includes confirmation that that the enzymes are nuclease- and endotoxin-free. In addition, the manufacturing process of TheraPure products follows ISO9001 and ISO13485 standards.

Features

  • Convenient stand-alone enzymes for easy workflow optimization
  • Animal-origin-free (AOF) raw materials used in manufacturing
  • No risk of prion or animal virus contamination
  • Reproducible and consistent results with validated quality testing
  • Regulatory compliant—β-lactam-free manufacturing technology
  • Suitable for translational research
  • Facilitates transition to GMP during mRNA vaccine development process
  • Scalable and available as OEM product

The exceptional quality of TheraPure products is supported by:

  • Certificates of analysis
  • Certificates of origin
  • TSE/BSE statement
Para uso exclusivo en investigación.
Especificaciones
Para utilizar con (aplicación)In vitro Transcription
Inactivation Temperature65°C
InhibidoresMetal chelators, transition metals (e.g., Zn), SDS, reducing agents (DTT and β-mercaptoethanol)
Tipo de productoADNasa I, sin ARNasa
Cantidad5000 U, 100 μL
Concentración50 U/μl
EnzimaDnase I, RNase-free
FormularioLíquido
Línea de productosTheraPure
Categoría de investigaciónDrug Development
Sensible a la inactivación del calorSí
Unit SizeEach